StockData
PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31

PURE BIOSCIENCE, INC.

Financials through Q3 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 15, 2026
$0.07−0.01 (-12.10%)

Close on Oct 19, 2026

Market cap
$7.33M
P/E (TTM)
–
Dividend yield
–

PURE BIOSCIENCE, INC. revenue by segment

By business segment

By product or service

RevenueTTM Q3 26TTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q1 24TTM Q4 23% of revenueYoY
Product [Member]$2.42M$2.40M$2.35M$2.20M$1.91M$1.86M$1.79M$1.96M$2.09M$2.05M$2.12M$1.87M100.0%+26.8%
PURE Hard Surface [Member]$1.98M$2.36M$2.31M$2.00M$1.71M$1.60M$1.54M$1.86M$2.00M$2.05M$2.06M$1.79M81.9%+15.6%
Royalty [Member]$3.00K$5.00K$4.00K$4.00K$5.00K$4.00K$5.00K$8.00K$6.00K$6.00K$6.00K$6.00K0.1%-40.0%
SILVERION [Member]–––$203.00K$194.00K$263.00K–$97.00K–––$85.00K––

By region

From the segment and revenue-disaggregation notes of Pure Bioscience's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.